Catalyst Wire Dossier Catalyst Wire Dossier

ViaDerm-hPTH(1-34)

hPTH(1-34) · TransPharma Medical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ViaDerm-hPTH(1-34), covering 2009-07-10 to 2009-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis [Phase 2]

See pricing